Medical Advocates
HCV Infection/Disease
 
Management
 
General Reports    
Directly Observed and Guided Therapy
Screening 
Pretreatment 
Drugs   
 Surgery  
Adherence        
Mental Health               
Nutrition/Weight Mngmt
Fatigue/Anemia
Special Populations		 Acute Hepatitis
 Recurrent Hepatitis
Chronic Hepatitis
HCV/HBV Coinfection
Non-Responders
Adverse Events
Alternative Therapies
Treatment Failure
Economics
Viral Resistance
Liver Transplants
 		 Resources
Videos








 
HCV Main Page Main New/Newsworthy    Home Page    
Last Update:  March 08, 2018
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
 
     Books/Reports/Documents/Videos
 
 

Treatment of Hepatitis C Virus Infection in Adults: Future Research Needs: Identification of Future Research Needs
From Comparative Effectiveness Review No. 76 [Internet].
 Chou R, Bougatsos C, Blazina I,  et al
Rockville (MD): Agency for Healthcare Research and Quality
 2013 Jan.
 Report

Treatment for Hepatitis C Virus Infection in Adults
Chou R, Hartung D, Rahman B, Wasson N, Cottrell E, Fu R.
Rockville (MD): Agency for Healthcare Research and Quality (US);
2012 Nov. Report No.: 12(13)-EHC113-EF.
 Report
Overcoming Stigmas To Treat Injectable Drug Users With Hepatitis C


Dr. Naveed Zafar Janjua on Impact of Hepatitis C Treatment Timing on HCC Risk

     Journal Papers, Abstracts, and Commentaries
 
 
Curative therapy of a hepatitis C infection due to an infected heart donor: 5-year outcomes after heart transplantation.
Jawad K, Feder S, Barten M, Garbade J.
 Eur J Cardiothorac Surg. 2018 Mar 3.
Abstract

Understanding hepatitis C intervention success: Qualitative findings from the HepCATT study.
Harris M, Bonnington O, Harrison G, et al  
 J Viral Hepat. 2018 Jan 25.
 Abstract

Assessing Hepatitis C Spontaneous Clearance and Understanding Associated Factors: A Systematic Review and Meta-Analysis.
 Aisyah DN, Shallcross L, Hully AJ,  et al
J Viral Hepat. 2018 Jan 18.
Abstract

Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b.
Kanda T, Nirei K, Matsumoto N, Higuchi T, et al
 World J Gastroenterol. 2017 Dec 14;23(46):8120-8127
 Abstract

FULL-TEXT ARTICLE
 Rapid and large-scale implementation of HCV treatment advances in France, 2007-2015
 Brouard C, Boussac-Zarebska M, Silvain C, et al
BMC Infect Dis. 2017 Dec 20;17(1):784
 Paper

Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
 Bregenzer A, Conen A, Knuchel J,  
 Swiss Med Wkly. 2017 Nov 29
 Abstract

Complication Rates After Total Hip and Knee Arthroplasty in Patients With Hepatitis C Compared With Matched Control Patients.
 Cancienne JM, Kandahari AM, Casp A
 J Am Acad Orthop Surg. 2017 Dec;25(12):e275-e281
 Abstract

Hepatitis C Virus: Patients' Risk Factors and Knowledge in an Urban Clinic Providing Wound Care.
 Pieper B, Sickon K.
 Wounds. 2017 Nov 20.
Abstract

Novel treatments for chronic hepatitis C: closing the remaining gaps.
 Alkhouri N, Lawitz E, Poordad F.
Curr Opin Pharmacol. 2017 Nov 6;37:107
 

Cost-effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers.
 Rattay T, Dumont P, Heinzow HS, Hutton DW.
 Gastroenterology. 2017 Oct 23
 Abstract

Should we treat acute hepatitis C? A decision and cost-effectiveness analysis.
 Bethea E, Chen Q, Hur C, et al
 Hepatology. 2017 Oct 23.
 Abstract

Implementation of a multidisciplinary, team-based model to treat chronic hepatitis C in the primary care setting: Lessons learned.
 Sokol R, Early J, Barner A, Gottfried S,
Healthc (Amst). 2017 Oct 18.
Abstract

Prospective longitudinal substance use patterns in patients preparing for hepatitis C treatment.
 North CS, Pollio DE, Sims OT, et al
 J Dual Diagn. 2017 Oct 16:0
 Abstract

Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study.
 Cento V, Aragri M, Teti E,  et al
J Antimicrob Chemother. 2017 Sep 18.
Abstract

Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies.
 Origa R, Ponti ML, Filosa A, et al 
Am J Hematol. 2017 Sep 20.
 Abstract

Can we go for a shorter treatment course in chronic hepatitis C? More inspiring cases.
 Zampino R, Vitrone M, Parrella A,  et al  
 J Chemother. 2017 Sep 19:1-2.
Abstract

When and how can nephrologists treat hepatitis C virus infection in dialysis patients?
Davis MI, Chute DF, Chung RT, Sise ME.
 Semin Dial. 2017 Sep 18.
Abstract

Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies - Effective treatment is coming.
 Ellwanger JH, de Lima Kaminski V,  et al
 Infect Genet Evol. 2017 Aug 12.
 Abstract

After successful hepatitis C virus antiviral therapy: It looks that normal alanine aminotransferase level is not the normal.
 El Kassas M, Alboraie M, Mostafa A,
J Clin Lab Anal. 2017 Jul 28.
Abstract

Application of Exposure-Response Analyses to Establish the Pharmacodynamic Similarity of a Once-Daily Regimen to an Approved Twice-Daily Dosing Regimen for the Treatment of HCV Infection.
 Polepally AR, Wang H, Marroum PJ,
 AAPS J. 2017 Jul 6.
Abstract


Modeling HCV cure after an ultra-short duration of therapy with direct acting agents.
 Goyal A, Lurie Y, Meissner EG,
Antiviral Res. 2017 Jun 30;144:281-285.
Abstract

Resistance to hepatitis C virus. Implications and therapeutic options.
 Llerena S, Cabezas J, Iruzubieta P, Crespo J.
 Gastroenterol Hepatol. 2017 Jun 21.
 Abstract

Treatment of hepatitis C with new fixed dose combinations.
 Soriano V.
 Expert Opin Pharmacother. 2017 Jun 23
 Abstract

No one size fits all - shortening duration of therapy with direct acting antivirals for Hepatitis C genotype 1 infection.
 El Sherif O, Afhdal N, Curry M.
 J Viral Hepat. 2017 Jun 5.
 Abstract

Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence.
 Rogal SS, McCarthy R, Reid A, et al 
Dig Dis Sci. 2017 May 18.
 Abstract

FULL-TEXT ARTICLE
 Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed.
 Yoshida K, Hai H, Tamori A, Teranishi Y. et al
Int J Mol Sci. 2017 May 3;18(5).
 Paper

FULL-TEXT ARTICLE
 Hepatitis C virus management: potential impact of nanotechnology.
 Elberry MH, Darwish NHE, Mousa SA.
Virol J. 2017 May 2;14(1):88.
Paper

Treating Hepatitis C in Patients with Renal Failure.
Lens S, Rodriguez-Tajes S, Llovet LP, et al
Dig Dis. 2017;35(4):339-346.
Abstract

Hepatitis C Virus-Genotype 3: Update on Current and Emergent Therapeutic Interventions.
 Johnson SW, Thompson DK, Raccor B.
Curr Infect Dis Rep. 2017 Jun;19(6):22.
Abstract

Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.
Sinakos E, Kountouras D, Koskinas J,  et al
 Br J Haematol. 2017 Apr 25. .
 Abstract

Hepatitis C infection: Updates on treatment guidelines.
 Pozza R, Hill C, Hefner AM,  et al
Nurse Pract. 2017 Apr 4.
 Abstract

The Role of e-Health in Optimizing Task-Shifting in the Delivery of Antiviral Therapy for Chronic Hepatitis C.
 Yoo ER, Perumpail RB, Cholankeril G, et al
Telemed J E Health. 2017 Apr 4.
 Abstract

Closing the Gap: The Challenges of Treating Hepatitis C Virus Genotype 3 Infection.
Martin MT, Deming P.
 Pharmacotherapy. 2017 Apr 4.
Abstract

Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape.
 Colpitts CC, Tawar RG, Mailly L,  et al
Gut. 2017 Mar 30.
 Abstract

FULL-TEXT ARTICLE
 High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments.
 Nien HC, Hsu SJ, Su TH, et al
PLoS One. 2017 Jan 20;12(1):e0170028.
Paper

Hepatitis C: efficacy and safety in real life.
 Flisiak R, Pogorzelska J, Flisiak-Jackiewicz M.
Liver Int. 2017 Jan;37 Suppl 1:26-32. .
 Abstract

Development and Preliminary Evaluation of an Integrated Cognitive-Behavior Treatment for Chronic Pain and Substance Use Disorder in Patients with the Hepatitis C Virus.
 Morasco BJ, Greaves DW, Lovejoy TI, et al
 Pain Med. 2016 Dec;17(12):2280-2290..
 Abstract

Management of chronic hepatitis C in 2017.
 von Köckritz L, Dufour JF.
Hamostaseologie. 2016 Nov 29.
 Abstract
 

Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C Infection on Hemodialysis.
 Goodkin DA, Bieber B, Jadoul M,  et al
Clin J Am Soc Nephrol. 2016 Dec 1
 Abstract

A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies.
 Bartlett SR, Wertheim JO, Bull RA, et al
 J Viral Hepat. 2016 Nov 24.
Abstract

Clinical importance of pharmacogenetics in the treatment of hepatitis C virus infection.
 Kamal AM, MitruŢ P, Kamal KC, et al 
Rom J Morphol Embryol. 2016;57(2 Suppl):675-680.
 Abstract

Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence.
 Nuño Solinís R, Arratibel Ugarte P, et al
 Infect Dis Ther. 2016 Oct 25. Review.
 Abstract

FULL-TEXT ARTICLE
 A practical overview of the treatment of chronic hepatitis C virus infection
 Khoo A, Tse E.
Aust Fam Physician. 2016 Oct;45(10):718-720.
 Paper

Value of Sustained Virologic Response in Patients with Hepatitis C as a Function of Time to Progression of End-Stage Liver Disease.
 Ward T, Gordon J, Jones B,
Clin Drug Investig. 2016 Sep 1.

Abstract

FULL-TEXT ARTICLE
 Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy.
 Spaan M, Hullegie SJ, Beudeker BJ, Kreefft K, et al
PLoS One. 2016 Jul 14;11(7):e0159243
 Paper

Update on Current Evidence for Hepatitis C Therapeutic Options in HCV Mono-infected Patients.
 Hull MW, Yoshida EM, Montaner JS.
 Curr Infect Dis Rep. 2016 Jul;18(7):22.
Abstract

Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time.
 Cuypers L, Ceccherini-Silberstein F, et al
 Rev Med Virol. 2016 Jul 12.
Abstract

Emerging biological agents for hepatitis C.
 Zuccaro V, Columpsi P, Apollinari A, et al
Expert Opin Emerg Drugs. 2016 Jun;21(2):219-24.
Abstract

Australian recommendations for the management of hepatitis C virus infection: a consensus statement.
 Thompson AJ.
Med J Aust. 2016 Apr 18;204(7):268-72.
 Abstract

Effects of Viral Eradication in Patients with HCV and Cirrhosis Differ With Stage of Portal Hypertension.
 Di Marco V, Calvaruso V, Ferraro D,  et al
Gastroenterology. 2016 Mar 31
 Abstract

Recent advances in managing chronic HCV infection: focus on therapy in patients with severe liver disease.
 Maan R, van der Meer AJ. et al
F1000Res. 2016 Mar 17;5. pii: F1000 Faculty Rev-367
 Abstract

FULL-TEXT ARTICLE
 Hepatitis C virus: A time for decisions. Who should be treated and when?
 Attar BM, Van Thiel DH.
World J Gastrointest Pharmacol Ther. 2016 Feb 6;7(1):33-40
 Paper

Successful achievement of sustained virological response to triple combination therapy containing simeprevir in two patients with chronic hepatitis C who had failed asunaprevir-daclatasvir combination therapy.
 Ozeki I, Nakajima T, Yamaguchi M, Kimura M, et al
Hepatol Res. 2016 Feb 9.
 Abstract

Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists.
 Deming P, Martin MT, Chan J, Dilworth TJ, et A;
Pharmacotherapy. 2016 Feb 5.
Abstract

FULL-TEXT ARTICLE
 New approaches in the treatment of hepatitis C.
 González-Grande R, Jiménez-Pérez M, González Arjona C, Mostazo Torres
J.World J Gastroenterol. 2016 Jan 28;22(4):1421-32
 Paper

The current treatment of Hepatitis C.
 Arleo A, Mangia A.
Minerva Gastroenterol Dietol. 2016 Jan 22.
 Abstract

Follow-up of patients with chronic hepatitis C and a sustained viral response.
 Serfaty L.
Liver Int. 2016 Jan;36 Suppl 1:67-71
Abstract

Why do I treat my patients with mild hepatitis C?
 Calvaruso V, Craxì A.
Liver Int. 2016 Jan;36 Suppl 1:7-12..
Abstract

The role of HCV proteins on treatment outcomes.
 Kumthip K, Maneekarn N.
Virol J. 2015 Dec 15;12(1):217
Abstract

Hepatitis C Virus: Current and Evolving Treatments for Genotype 4.
Asselah T, Bourlière M.  
Gastroenterol Clin North Am. 2015 Dec;44(4):859-70
Abstract

Hepatitis C Virus: Current and Evolving Treatments for Genotypes 2 and 3.
Ampuero J, Romero-Gómez M.
 Gastroenterol Clin North Am. 2015 Dec;44(4):845-57.
Abstract

Variation in Treatment Priorities for Chronic Hepatitis C: A Latent Class Analysis.
Fraenkel L, Lim J, Garcia-Tsao G,  et al
Patient. 2015 Oct 30.
Abstract

Hepatitis C virus treatment in the real world: optimising treatment and access to therapies.
Zoulim F, Liang TJ, Gerbes AL,  et al
Gut. 2015 Nov;64(11):1824-33.  
Abstract

Regimens for the Hepatitis C Treatment-Naive Patient.
Ayoub WS, Tran TT.
Clin Liver Dis. 2015 Nov;19(4):619-27.
 Abstract

HCV Council - Critical Appraisal of Data: Recommendations for Clinical Practice in a Rapidly Evolving Therapeutic Landscape.
Reau N, Fried MW, Nelson DR, et al
Liver Int. 2015 Oct 28.
 Abstract

All-oral interferon-free treatments: The end of hepatitis C virus story, the dream and the reality.
 Adinolfi LE, Guerrera B.
World J Hepatol. 2015 Oct 8;7(22):2363-8.
Abstract

Treatment of HCV in Patients who Failed First-Generation PI Therapy: a Review of Current Literature.
Kwo PY, Badshah MB.
Curr Gastroenterol Rep. 2015 Oct;17(10):462.
Abstract

Current guidelines and prioritizing treatment of hepatitis C virus in HIV-infected patients.
 Feeney ER, Chung RT, Yazdanpanah Y.
 Curr Opin HIV AIDS. 2015 Sep;10(5):323-9.
Abstract

Hepatitis C: Treatment of difficult to treat patients.
 Hilgenfeldt EG, Schlachterman A, Firpi RJ.
World J Hepatol. 2015 Jul 28;7(15):1953-63.
Abstract

Novel Hepatitis C Treatment and the Impact on Kidney Transplantation.
 Sawinski D, Bloom RD.
Transplantation. 2015 Jul 25.
 Abstract

Optimizing patient treatment decisions in an era of rapid technological advances: the case of hepatitis C treatment.
Liu S, Brandeau ML, Goldhaber-Fiebert JD.
Health Care Manag Sci. 2015 Jul 19.
Abstract

FULL-TEXT ARTICLE
 Treatment guidelines for Hepatitis C in Spain.
 Crespo-Casal M.
 Rev Esp Sanid Penit. 2015 Oct;17(2):37-47
 Paper

FULL-TEXT ARTICLE
 Rational Design and Adaptive Management of Combination Therapies for Hepatitis C Virus Infection.
 Ke R, Loverdo C, Qi H,  et al
PLoS Comput Biol. 2015  Jun 30;11(6):e1004040
 Paper

The patient's journey with chronic hepatitis C from interferon plus ribavirin to interferon- and ribavirin-free regimens: a study of health-related quality of life.
Younossi ZM, Stepanova M, Nader F,  et al
Aliment Pharmacol Ther. 2015 Jun 9.
Abstract

Long-term treatment outcomes of patients infected with Hepatitis C virus: a systematic review and meta-analysis of the survival benefit of achieving a Sustained Virological Response.
Simmons B, Saleem J, Heath K, C et al
 Clin Infect Dis. 2015 May 17.  .
 Abstract

Hepatitis C Management and the Infectious Diseases Physician: A Survey of Current and Anticipated Practice Patterns.
Chastain CA, Beekmann SE, Wallender EK,  et al
Clin Infect Dis. 2015 May 15.
Abstract

Simultaneously Targeting the NS3 Protease And Helicase Activities For More Effective Hepatitis C Virus Therapy.
Ndjomou J, Corby MJ, Sweeney NL, et al
ACS Chem Biol. 2015 May 11
 Abstract

Treatment of hepatitis C in difficult-to-treat patients.
 Ferenci P.
Nat Rev Gastroenterol Hepatol. 2015 Apr 21.
 Abstract

Effect of addition of statins to antiviral therapy in HCV infected persons: Results from ERCHIVES.
Butt AA, Yan P, Bonilla H,  et al
Hepatology. 2015 Apr 6.
 Abstract

FULL-TEXT ARTICLE
Chronic hepatitis C genotype 1 treatment roadmap for resource constrained settings.
Lim SG.
 World J Gastroenterol. 2015 Feb 14;21(6):1972-81.
 Paper

Long-term follow-up of successful hepatitis C virus therapy: waning immune responses and disappearance of liver disease are consistent with cure.
Hedenstierna M, Weiland O, Brass A, et al
Aliment Pharmacol Ther. 2015 Jan 28.
 Abstract

Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2.
Gane E, Kershenobich D, Seguin-Devaux C ,et al
 J Viral Hepat. 2015 Jan;22 Suppl 1:46-73
 Abstract

Treatment of Hepatitis C in Liver Transplant Patients: Interferon OUT, Direct Antiviral Combos IN.
Price JC, Terrault NA.
 Liver Transpl. 2015 Jan 20.
Abstract

Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open-label, cohort study.
Gragnani L, Fognani E, Piluso A, et al
Hepatology. 2014 Nov 27.
Abstract

New kids on the block-step by step to an ideal HCV therapy.
 Cornberg M, Manns MP.
Lancet. 2014 Nov 11. pii: S0140-6736(14)62008-0.
Abstract

Strategies for the treatment of Hepatitis C in an era of interferon-free therapies: what public health outcomes do we value most?
Innes H, Goldberg D, Dillon J, Hutchinson SJ.
 Gut. 2014 Nov 6.
 Abstract

FULL-TEXT ARTICLE
 Recent advances in the treatment of hepatitis C.
 Dhingra A, Kapoor S, Alqahtani SA.
Discov Med. 2014 Oct;18(99):203-8.
 Paper

The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control Study.
Sharafi H, Alavian SM, Behnava B, et al
 Hepat Mon. 2014 Oct 1;14(10):e22649.
Abstract

Screening, Diagnosis, Treatment, and Management of Hepatitis C: A Novel, Comprehensive, Online Resource Center for Primary Care Providers and Specialists.
 Lebovics E, Czobor K.
Am J Med. 2014 Oct 9. pii: S0002-9343(14)00888-2.
Abstract

New hepatitis C treatments: pharmacological considerations and potential for drug interactions.
Chtioui H, Buclin T, Moradpour D.
Rev Med Suisse. 2014 Sep 3;10(440):1600-4,.
 Abstract

FULL-TEXT ARTICLE
 Challenging clinical cases in HCV infection.
 Strazzulla A, Matera G, Mammone S, et al
BMC Infect Dis. 2014 Sep 5;14 Suppl 5:S7.
Paper

Benefits of Hepatitis C Virus treatment: a balance of preventing onwards transmission and re-infection.
 de Vos AS, Kretzschmar ME.
 Math Biosci. 2014 Sep 18.
 Abstract

FULL-TEXT PDF ARTICLE
 Fighting an uphill battle": experience with the HCV triple therapy: a qualitative thematic analysis.
 Rasi M, Künzler-Heule P, Schmid P,  et al
BMC Infect Dis. 2014 Sep 18;14(1):507. .
 Paper

Hepatitis C virus genotype 3: a genotype that is not 'easy-to-treat'
 Buti M, Esteban R.
 Expert Rev Gastroenterol Hepatol. 2014 Sep 15:1-11.
Abstract

Autophagy in HCV Infection: Keeping Fat and Inflammation at Bay.
 Vescovo T, Refolo G, Romagnoli A, et al
Biomed Res Int. 2014;2014:265353.
 Abstract

Early viral kinetics during hepatitis C virus genotype 6 treatment according to IL28B polymorphisms.
 Akkarathamrongsin S, Payungporn S, Thong VD,  et al
World J Gastroenterol. 2014 Aug 14
Abstract

Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for intervention.
 Moorman AC, Xing J, Ko S,  et al
Hepatology. 2014 Aug 13
Abstract

Treatment of hepatitis C: a systematic review.
Kohli A, Shaffer A, Sherman A, Kottilil S.
JAMA. 2014 Aug 13;312(6):631-40
 Abstract

New Therapies for Hepatitis C: Considerations in Patients with Renal Impairment.
Zimner-Rapuch S, Janus N, Deray G, Launay-Vacher V.
Drugs. 2014 Jul 25
 Abstract

Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy.
 Mennini FS, Marcellusi A, Andreoni M, et al 
Clinicoecon Outcomes Res. 2014 Jun 19;6:303-10
 Abstract

Medicinal plants used in malaria treatment by Prometra herbalists in Uganda.
Adia MM, Anywar G, Byamukama R,  et al
J Ethnopharmacol. 2014 Jun 11.
Abstract

Restoration of HCV-specific CD8+ T-cell function by Interferon-free therapy.
 Martin B, Hennecke N, Lohmann V, et al
J Hepatol. 2014 Jun 3.
 Abstract

FULL-TEXT ARTICLE
 The hepatitis C cascade of care: identifying priorities to improve clinical outcomes.
 Linas BP, Barter DM, Leff JA,  et al
PLoS One. 2014 May 19;9(5):e97317.
 Paper

FULL-TEXT ARTICLE
 Therapy of Hepatitis C - Back to the Future.
 Liang TJ, Ghany MG.
N Engl J Med. 2014 May 4
 Paper

The Rapid Evolution of Treatment Strategies for Hepatitis C.
Muir AJ.
Am J Gastroenterol. 2014 Apr 15.
Abstract

Reversal, maintenance or progression: What happens to the liver after a virologic cure of hepatitis C?
 Lee YA, Friedman SL.
Antiviral Res. 2014 Apr 9.
 Abstract

Strategies to manage hepatitis C virus (HCV) disease burden.
 Wedemeyer H, Duberg AS, Buti M, et al
J Viral Hepat. 2014 May;21 Suppl 1:60-89.
Abstract

 Curing Chronic Hepatitis C - The Arc of a Medical Triumph.
 Chung RT, Baumert TF.
 N Engl J Med. 2014 Apr 10
 Abstract

FULL-TEXT ARTICLE
 Challenges in managing hepatitis C virus infection in cancer patients.
 Borchardt RA, Torres HA.
World J Gastroenterol. 2014 Mar 21;20(11):2771-2776
 Paper

What are the pros and cons of the use of host-targeted agents against hepatitis C?
 Pawlotsky JM.
Antiviral Res. 2014 Feb 25.
 Abstract

Treatment of hepatitis C virus genotype 3-infection.
 Pol S, Vallet-Pichard A, Corouge M.
Liver Int. 2014 Feb;34 Suppl 1:18-23
 Abstract

How to optimize current treatment of genotype 2 hepatitis C virus infection.
 Marciano S, Gadano AC.
Liver Int. 2014 Feb;34 Suppl 1:13-7.
 Abstract

Treatment of Chronic Hepatitis C Virus Infection: Some Remaining Obstacles in the United States.
 Searson G, Engelson ES, Carriero D, Kotler DP.
 Liver Int. 2014 Jan 13.
Abstract

Predictors of hepatitis C treatment response: what's new?
Berry L, Irving W.
 Expert Rev Anti Infect Ther. 2014 Jan 3.
 Abstract

FULL-TEXT ARTICLE
 Prospects for nucleic acid-based therapeutics against hepatitis C virus.
 Lee CH, Kim JH, Lee SW.
World J Gastroenterol. 2013 Dec 21;19(47):8949-8962
 Paper

Predictors of the therapeutic response in hepatitis C. A 2013 update.
 Arnaud C, Trépo C, Petit MA. 
Clin Res Hepatol Gastroenterol. 2013 Nov 20.
 Abstract

Treatment as prevention and cure towards global eradication of hepatitis C virus.
 Hagan LM, Wolpe PR, Schinazi RF.
Trends Microbiol. 2013 Nov 13.
 Abstract

After the Cure: Management of HCV After Achievement of SVR.
 Zator ZA, Chung RT.
 Curr HIV/AIDS Rep. 2013 Nov 12.
 Abstract

FULL-TEXT ARTICLE
 Hepatitis C, stigma and cure.
 Marinho RT, Barreira DP.
World J Gastroenterol. 2013 Oct 28;19(40):6703-
 Paper

FULL-TEXT ARTICLE
 Hepatitis C genotype 6: A concise review and response-guided therapy proposal.
 Bunchorntavakul C, Chavalitdhamrong D, Tanwandee T.
World J Hepatol. 2013 Sep 27;5(9):496-504. .
 Paper

Impact of Hepatitis C Treatment Initiation on Adherence to Concomitant Medications.
 Pizzirusso M, Lin J, Head C,  et al
J Assoc Nurses AIDS Care. 2013 Sep 24..
 Abstract

Viral Breakthrough Is Associated With Resistance Using Direct Acting Agents in Patients Treated for Chronic Hepatitis C Infection.
 Zhou K, Ferguson J, Bau S, Saab S.
J Clin Gastroenterol. 2013 Sep 16
 Abstract

Treatment decisions and contemporary versus pending treatments for hepatitis C.
Trembling PM, Tanwar S, Rosenberg
WM, Dusheiko GM.
Nat Rev Gastroenterol Hepatol. 2013 Sep 10.
Abstract

Current and future therapies for hepatitis C virus infection: from viral proteins to host targets.
Imran M, Manzoor S, Khattak NM
Arch Virol. 2013 Aug 25.
 Abstract

Pretreatment predictive factors for hepatitis C therapy outcome: relevance of anti-E1E2 antibodies compared to IP-10 and IL28B genotypes.
 Arnaud C, Pradat P, Spaziante M,  et al
Antivir Ther. 2013 Aug 15.
 Abstract

Containing "The Great Houdini" of viruses: Combining direct acting antivirals with the host immune response for the treatment of chronic hepatitis C.
 Ahlén G, Frelin L, Brenndörfer ED,  et al
Drug Resist Updat. 2013 Aug 1.
 Abstract

Hepatitis C Virus: Standard-of-Care Treatment.
Pawlotsky JM.
 Adv Pharmacol. 2013;67:169-215.
 Abstract

FULL-TEXT ARTICLE
 Management algorithm for genotype 1 hepatitis C virus.
 Kim AY.
F1000Prime Rep. 2013 Jul 1;5:24.
Paper

To consider negative viral loads below the limit of quantification can lead to errors in the diagnosis and treatment of hepatitis C virus infection.]Acero Fernández D, Ferri Iglesias MJ,  et al
Gastroenterol Hepatol. 2013 Jul 9.
 Abstract

Hepatitis C treatment in patients with kidney disease.
Fabrizi F, Aghemo A, Messa P
 Kidney Int. 2013 Jul 3.
Abstract

The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection.
Bartenschlager R, Lohmann V, Penin F.
 Nat Rev Microbiol. 2013 Jun 10. .
 Abstract

Noncompliance with guidelines for the treatment of hepatitis C is frequent in daily practice.
 Niederau C, Mauss S, Böker K, et al
 Eur J Gastroenterol Hepatol. 2013 Jun 6
 Abstract

A novel program for treating patients with trimorbidity: hepatitis C, serious mental illness, and active substance use.
 Sockalingam S, Blank D, Banga CA,  et al
Eur J Gastroenterol Hepatol. 2013 May 15
 Abstract

Hepatitis C antiviral treatment outcomes are comparable between clinical trial participants and recipients of standard-of-care therapy: an analysis of trial effect.
 Kelly EM, Cooper CL.
Eur J Gastroenterol Hepatol. 2013 May
 Abstract

Impact of sustained virologic response on quality of life in chronic HVC carriers.
Daltro-Oliveira R, Morais-de-Jesus M, Pettersen KM,  et al
Ann Hepatol. 2013 May-Jun;12(3):399-407.|
 Abstract

HCV Treatment - No More Room for Interferonologists?
 Drenth JP
N Engl J Med. 2013 Apr 23..
 Abstract

Hepatitis C virus therapy update 2013.
Casey LC, Lee WM.
 Curr Opin Gastroenterol. 2013 May;29(3):243-9..
 Abstract

Micromanaging Hepatitis C Virus.
 Lieberman J, Sarnow P.
 N Engl J Med. 2013 Mar 27.
Abstract

Treatment of HCV Infection by Targeting MicroRNA.
Janssen HL, Reesink HW, Lawitz EJ et al
N Engl J Med. 2013 Mar 27. .
 Abstract

Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.
 Thibault PA, Wilson JA.
Pharmacol Res. 2013 Mar 26.
Abstract

Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial.
Deterding K, Grüner N, Buggisch P,  et al
Lancet Infect Dis. 2013 Mar 21
 Abstract

Future therapies for chronic hepatitis C.
Dabbouseh NM, Jensen DM.
Nat Rev Gastroenterol Hepatol. 2013 Feb 19
 Abstract

A Survey of Hepatitis C Treatment Clinical Practice Patterns Using the Newly Approved Protease Inhibitors.
 Chen EY, Lee WM, Hynan LS, Singal AG.
 J Clin Gastroenterol. 2013 Mar .
 Abstract

Closing in on the Target: Sustained Virologic Response in Hepatitis C Virus Genotype-1 Infection Response-Guided Therapy.Lontok E, Mani N, Harrington PR, Miller V
 Clin Infect Dis. 2013 Jan 29
 Abstract

Influence of healthcare-associated factors on the efficacy of hepatitis C therapy.
Daw MA, Dau AA, Agnan MM.
 ScientificWorldJournal. 2012;2012:580216. .
 Abstract

Treatment of hepatitis C: how will we use viral kinetics, response-guided therapy?
 Pawlotsky JM.
Curr Gastroenterol Rep. 2013 Feb;15(2):309. .
 Abstract

Should HCV discordant couples with a seropositive male partner be treated with assisted reproduction techniques (ART)?
Savasi V, Oneta M, Parrilla B, Cetin I.
Eur J Obstet Gynecol Reprod Biol. 2013 Jan 11.
Abstract

HCV therapy in HIV-infected patients
Sulkowski MS.
Liver Int. 2013 Feb;33 Suppl 1:63-7.
Abstract

Evaluation of the HCV-Infected Patient: the Initial Encounter.
 Bräu N.
Clin Infect Dis. 2012 Dec 12..
 Abstract

FULL-TEXT REPORT
 Hepatitis C virus: a critical appraisal of new approaches to therapy.
 Nelson DR, Jensen DM, Sulkowski MS, et al
Hepat Res Treat. 2012;2012:138302.
Paper

Playing the numbers: how hepatitis C patients create meaning and make healthcare decisions from medical test results.
Perzynski AT, Terchek JJ, Blixen CE, Dawson NV.
Sociol Health Illn. 2012 Sep 26.
 Abstract

Evaluation and treatment of hepatitis C in patients with human immunodeficiency virus.
 Bakaj G, Valasiuk T, Prabhukhot R, Siraj D
South Med J. 2012 Oct;105(10):500-3. ..
 Abstract

Hepatitis C therapy in non-genotype 1 patients: the near future.
Wartelle-Bladou C, Le Folgoc G, Bourlière M, Lecomte L.
J Viral Hepat. 2012 Aug;19(8):525-36.
Abstract

Recent successes and noteworthy future prospects in the treatment of chronic hepatitis C.
Fox AN, Jacobson IM.
 Clin Infect Dis. 2012 Jul;55 Suppl 1:S16-24.
 Abstract

Hepatitis C virus prevention, care, and treatment: from policy to practice.
Ward JW, Valdiserri RO, Koh HK.
 Clin Infect Dis. 2012 Jul;55 Suppl 1:S58-63.
 Abstract

Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in
Advanced Hepatitis C.
Morishima C, Shiffman ML, Dienstag JL, et al
 Am J Gastroenterol. 2012 Jun 12.
Abstract

Hepatitis C treatment outcomes in Australian clinics.
Gidding HF, Law MG, Amin J,
Med J Aust. 2012 Jun 8;196(10):633-7.
 Abstract

Treatment Results of Chronic Hepatitis C Genotype 5 and 6 Infections in Germany.
Mauss S, Berger F, Vogel M, et al
Z Gastroenterol. 2012 May;50(5):441-444
 Abstract

Hepatitis C virus therapeutics: at the end of the beginning.
Schooley RT.
Top Antivir Med. 2012 Apr;20(1):17-9.
 Abstract

FULL-TEXT ARTICLE
 Advances in the treatment of hepatitis C virus infection.
Thomas DL.
 Top Antivir Med. 2012 Apr;20(1):5-10..
 Paper

Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy.
Giannini EG, Marenco S, Fazio V, et al
Liver Int. 2012 Apr 4..
 Abstract

FULL-TEXT PDF ARTICLE
 Current status and future directions in the management of chronic hepatitis C.
Aman W, Mousa S, Shiha G, Mousa SA. |
 Virol J. 2012 Mar 2;9(1):57.
 Paper

Primary care-based interventions are associated with increases in hepatitis C virus testing
for patients at risk.
Litwin AH, Smith BD, Drainoni ML, |et al
 Dig Liver Dis. 2012 Feb 17.
Abstract

Response-guided therapy for patients with chronic hepatitis who have high viral loads of hepatitis C virus genotype 2.
Yamaguchi Y, Tamori A, Tanaka Y, et al
Hepatol Res. 2012 Feb 9. .
 Abstract

Optimal treatment duration for patients with HCV genotype 1 infection.
Ferenci P.
J Viral Hepat. 2012 Jan;19 Suppl 1:7-13...
 Abstract

New developments in HCV therapy.
Kronenberger B, Zeuzem S.
J Viral Hepat. 2012 Jan;19 Suppl 1:48-51
 Abstract

2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines.
Calvaruso V, Craxì A.
Liver Int. 2012 Feb;32 Suppl 1:2-8
 Abstract

Barriers to hepatitis C treatment.
McGowan CE, Fried MW.
 Liver Int. 2012 Feb;32 Suppl 1:151-6. .
 Abstract

The future for the treatment of genotype 4 chronic hepatitis C.
Esmat G, El Raziky M, El Kassas M,  et al
 Liver Int. 2012 Feb;32 Suppl 1:146-50..
 Abstract

Future treatment of patients with HCV cirrhosis.
Bourlière M, Khaloun A, Wartelle-Bladou C, et al
 Liver Int. 2012 Feb;32 Suppl 1:113-9.
Abstract

Optimization of Comorbidity Therapy to Achieve Sustained Viral Response in HCV Patients.
Ucciferri C, Vecchiet J, Pizzigallo E, Falasca K.
Hepatogastroenterology. 2011 Dec 22;59(117)..
 Abstract

Management of Hepatitis C in Patients with Chronic Kidney Disease.
Al-Freah MA, Zeino Z, Heneghan MA. et al
Curr Gastroenterol Rep. 2011 Dec 10.
 Abstract

Very Low Viral Load (VLVL) Relapse Following Treatment of Naïve Patients with Chronic Hepatitis C.
Hoefs JC, Aulakh VS, Ilagan BJ.
 Dig Dis Sci. 2011 Dec 4..
 Abstract

Treatment of Non-Genotype 1 Hepatitis C Virus Patients.
Mangia A, Mottola L.
 Curr Gastroenterol Rep. 2011 Nov 24..
 Abstract

General practitioner attitudes to prescribing hepatitis C antiviral therapy in a community setting.
Lambert SM, Page AN, Wittmann J,  et al
 Aust J Prim Health. 2011;17(3):282-7.
 Abstract

Naives, Nonresponders, Relapsers: Who Is There Left to Treat?
Desai AP, Reau N.
 Clin Liver Dis. 2011 Aug;15(3):483-495..
 Abstract

Management of the Treatment-Experienced Patient Infected with Hepatitis C Virus Genotype 1: Options and Considerations.
Khalid O, Bacon BR.
 Clin Liver Dis. 2011 Aug;15(3):573-583..
 Abstract

FULL-TEXT ARTICLE
 Optimal Control of Hepatitis C Antiviral Treatment Programme Delivery for Prevention amongst a Population of Injecting Drug Users.
Martin NK, Pitcher AB, Vickerman P, et al  
PLoS One. 2011;6(8):e22309.
 Paper

FULL-TEXT ARTICLE
 Management of hepatitis C virus (HCV) infection in drug substitution programs.
Witteck A, Schmid P, Hensel-Koch K,  et al
Swiss Med Wkly. 2011 May 27;141:w13193
 Paper

'Knowledge, attitudes and behaviours associated with the provision of hepatitis C care by Canadian family physicians.
Cox J, Graves L, Marks E, et al
J Viral Hepat. 2011 Jul;18(7):e332-40.
 Abstract

UKHCDO guidelines on the management of HCV in patients with hereditary bleeding disorders 2011.
Wilde JT, Mutimer D, Dolan G,  et al
Haemophilia. 2011 Jun 9..
 Abstract

Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers.
Arora S, Thornton K, Murata G,  et al
N Engl J Med. 2011 Jun 1.
 Abstract

Future perspective in the treatment of chronic hepatitis C.
Fernández-Montero JV, Soriano V.
Rev Esp Sanid Penit. 2011 Jun;13(1):21-29
 Abstract
Racial differences in hepatitis C treatment eligibility.
Melia MT, Muir AJ, McCone J, et al
 Hepatology. 2011 Apr 12.
Abstract

Five-year follow-up of patients with chronic C hepatitis and sustained virological response.
 Puig Del Castillo I, Miquel Planas M, et al
Rev Esp Enferm Dig. 2011 Feb;103(2):56-61..
 Abstract

Treatment of acute hepatitis C virus infection in HIV+ patients: Dutch recommendations for management.
 Arends JE, Lambers FA, van der Meer JT,  et al
Neth J Med. 2011 Jan;69(1):43-9.
 Abstract

Impact of hepatitis C virus infection on the course and outcome of patients with acute alcoholic hepatitis.
Singal AK, Sagi S, Kuo YF, Weinman S
Eur J Gastroenterol Hepatol. 2011 Jan 20
 Abstract

Treatment of hepatitis C virus infection in patients with end-stage renal disease.
 Liu CH, Kao JH."
 J Gastroenterol Hepatol. 2011 Feb;26(2):228-239. ..
 Abstract

Hepatitis C - diagnostics and treatment.
 Dalgard O, Konopski Z, Bosse FJ,  et al
Tidsskr Nor Laegeforen. 2011 Jan 7;131(1):E1-E8
 Abstract

 
 
     Conference Reports, Abstracts, and Posters
 
  Long term benefit of HCV treatment on the liver. Evidence from the l'actuel's viral hepatitis cohort (HEPVIRAC)
 N. Machouf, M. Poliquin, S. Vézina, et al
 (XX International AIDS Conference)
 Abstract

Knowledge and awareness of current hepatitis C treatment strategies among nurses who care for persons living with HIV in the United States:
a call for provider education
J. Kwong, S. Willard, R. Carroll, et al
 (XIX International AIDS Conference)
 Abstract
Directly Observed and Guided Therapy
 
    Journal Papers, Abstracts, and Commentaries
 
  Response-Guided Therapy in Patients with Genotype 1 HCV: Current Status and Future Prospects.
Lawitz EJ, Membreno FE.
J Gastroenterol Hepatol. 2014 May 22
 Abstract

Directly observed therapy for the treatment of hepatitis C virus infection in current and former injectiondrug users.
 Grebely J, Raffa JD, Meagher C, et al 
J Gastroenterol Hepatol. 2007 Jul 20;
Abstract
Screening
 
    Journal Papers, Abstracts, and Commentaries
 
  Is screening for interferon retinopathy in hepatitis C justified?
 Cuthbertson FM, Davies M, McKibbin M. 
Br J Ophthalmol. 2004 Dec;88(12):1518-1520.
 Abstract
Pretreatment
 
    Journal Papers, Abstracts, and Commentaries
 
  Pretreatment sequence diversity differences in the full-length Hepatitis C Virus open reading frame correlate with early response to therapy.
 Donlin MJ, Cannon NA, Yao E, et al
J Virol. 2007 May 23;
 Abstract
Adherence to Drug Therapy
 
    Journal Papers, Abstracts, and Commentaries
 
 
Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence.
 Rogal SS, McCarthy R, Reid A, et al 
Dig Dis Sci. 2017 May 18.
 Abstract

Instrumental support to facilitate hepatitis C treatment adherence: Working around shortfalls in shared-care.
 Sublette VA, Hopwood M, George J,  et al
Psychol Health Med. 2014 Jul 7:1-12.
 Abstract

Adherence During Antiviral Treatment Regimens for Chronic Hepatitis C: A Qualitative Study of Patient-reported Facilitators and Barriers.
Evon DM, Golin CE, Bonner JE,  et al
J Clin Gastroenterol. 2014 May 13
 Abstract

FULL-TEXT ARTICLE
 Factors influencing adherence in Hepatitis-C infected patients: a systematic review.
 Mathes T, Antoine SL, Pieper D.
BMC Infect Dis. 2014 Apr 15;14(1):203.
 Paper

Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study.
 Marcellin P, Chousterman M, Fontanges T,  et al
 Liver Int. 2011 Apr;31(4):516-524
 Abstract

The effect of adherence to therapy on sustained response in daily or three times a week "interferon alpha-2b plus ribavirin treatment of naive and nonresponder chronic hepatitis C patients.
Raptopoulou M, Tsantoulas D, Vafiadi I, et al 
J Viral Hepat. 2005 Jan;12(1):91-5
 Abstract
 
Impact of adherence on the outcome of antiviral therapy for chronic hepatitis C.
Mulhall BP, Younossi Z.
J Clin Gastroenterol. 2005 Jan;39(1 Suppl):S23-7
 Abstract
Mental Health Challenges
 
    Journal Papers, Abstracts, and Commentaries
 
 
Chronic Hepatitis C and Antiviral Treatment Regimens: Where Can Psychology Contribute?
Evon DM, Golin CE, Fried MW, Keefe FJ.
J Consult Clin Psychol. 2012 Jun 25.
Abstract

Management of patients with hepatitis C by French psychologists and psychiatrists: A practical investigation.
 Lang JP, Schoeffler M, Michel L, et al
Gastroenterol Clin Biol. 2009 Nov 24
Abstract

Managing depression during hepatitis C treatment.
 Sockalingam S, Abbey SE.
Can J Psychiatry. 2009 Sep;54(9):614-25
 Abstract

 
     Conference Reports, Abstracts, and Posters
 
  Depression Changes in Hepatitis C Patients Undergoing Antiviral Therapy
 KM Simpson, A Verma, DM Evon, et al
(136th APHA)
 Abstract
Nutrition/Weight Management
 
     Journal Papers, Abstracts, and Commentaries
 
 
The impact of nutrition on quality of life of patients with hepatitis C.
 Silva LD, Bering T, Rocha GA.
 Curr Opin Clin Nutr Metab Care. 2017 Jun 15.
Abstract

Vitamin D deficiency and vitamin D therapy in chronic hepatitis C.
Ladero JM, Torrejón MJ, Sánchez-Pobre P, et al
Ann Hepatol. 2013 Mar;12(2):199-204.
 Abstract

Preventive versus "on-demand" nutritional support during antiviral treatment for hepatitis C: a randomized controlled trial.
 Huisman EJ, van Hoek B, van Soest H, et al
J Hepatol. 2012 Jun 30.
Abstract
Fatigue/Anemia
 

     Journal Papers, Abstracts, and Commentaries

 
Fatigue Before, During and After Antiviral Therapy of Chronic Hepatitis C: Results from the Virahep-C Study.
Sarkar S, Jiang Z, Evon DM,
J Hepatol. 2012 Jun 30.
 Abstract

Modafinil and armodafinil treatment for fatigue for HIV-positive patients with and without chronic hepatitis C.
Rabkin JG, McElhiney MC, Rabkin R.
 Int J STD AIDS. 2011 Feb;22(2):95-101.
 Abstract
 
Special Populations
 

Substance Users
  Integrated Care Increases Treatment and Improves Outcomes of Patients with Chronic HCV Infection and Psychiatric Illness or Substance Abuse.
 Ho SB, Bräu N, Cheung R,  et al
Clin Gastroenterol Hepatol. 2015 Feb 24.
 Abstract

Hepatitis C treatment for multimorbid patients with substance use disorder in a primary care-based integrated treatment centre:
a retrospective analysis.
Brunner N, Senn O, Rosemann T, Falcato L, et al
Eur J Gastroenterol Hepatol. 2013 Apr 8.
Abstract
Acute Hepatitis
 

     Journal Papers, Abstracts, and Commentaries

 
Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment.
 Sagnelli E, Santantonio T, Coppola N,  et al
Infection. 2014 Mar 12..
 Abstract

Diagnosis and treatment of acute hepatitis C virus infection.
Boesecke C, Wedemeyer H, Rockstroh JK.
 Infect Dis Clin North Am. 2012 Dec;26(4):995-1010
 Abstract

Treatment of acute hepatitis C infection in HIV-infected patients.
Boesecke C, Rockstroh JK.
 Curr Opin HIV AIDS. 2011 Apr 23.
 Abstract

Treatment of acute HCV infection.
 Grebely J, Matthews GV, Dore GJ.
Nat Rev Gastroenterol Hepatol. 2011 Mar 22.
 Abstract

Management of Acute Hepatitis C.
 Maheshwari A, Thuluvath PJ.  
 Clin Liver Dis. 2010 Feb;14(1):169-176.
 Abstract
 
Recurrent Hepatitis
Post-Transplant HCV Recurrence

     Journal Papers, Abstracts, and Commentaries

 
FULL-TEXT ARTICLE
 Re-re-treatment of hepatitis C virus: Eight patients who relapsed twice after direct-acting-antiviral drugs.
 Hartman J, Bichoupan K, Patel N,
World J Gastroenterol. 2015 Nov 21;21(43):12430-8.
 Paper

Investigation of residual hepatitis C virus in presumed recovered subjects.
Fujiwara K, Allison RD, Wang RY, et al
 Hepatology. 2012 Jun 23.
Abstract

Transfusion has no effect on recurrence in hepatitis C after liver transplantation.
Rice MJ, Wendling A, Firpi RJ, et al
Acta Anaesthesiol Scand. 2010 Nov;54(10):1224-32.
Abstract
 
Chronic Hepatitis
 

   Journal Papers, Abstracts, and Commentaries 
 
 

FULL-TEXT ARTICLE
 Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response.
 Welsch C, Efinger M, von Wagner Met al ,  
PLoS One. 2017 Feb 14;12(2):e0171755.
Paper

Direct-acting antiviral drugs for the treatment of chronic hepatitis c virus infection: Interferon free is now.
 Florian J, Mishra P, Arya V, et al
Clin Pharmacol Ther. 2015 Jul 14.
 Abstract

Integrated Care Increases Treatment and Improves Outcomes of Patients with Chronic HCV Infection and Psychiatric Illness or Substance Abuse.
 Ho SB, Bräu N, Cheung R,  et al
Clin Gastroenterol Hepatol. 2015 Feb 24.
 Abstract

FULL-TEXT ARTICLE
 Individualization of chronic hepatitis C treatment according to the host characteristics.
 Gatselis NK, Zachou K, Saitis A, et al
World J Gastroenterol. 2014 Mar 21;20(11):2839-2853
 Paper

FULL-TEXT ARTICLE
 Chronic hepatitis C: future treatment.
 Wendt A, Adhoute X, Castellani P,  et al
Clin Pharmacol. 2014 Jan 8;6:1-17.
 Paper

Role of IL28B for chronic hepatitis C treatment toward personalized medicine.
 Matsuura K, Watanabe T, Tanaka Y.
J Gastroenterol Hepatol. 2013 Dec 10
 Abstract

FULL-TEXT ARTICLE
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1).
 Fuller MJ, Callendret B, Zhu B,  et al 
Proc Natl Acad Sci U S A. 2013 Aug 26
 Paper

Presentation, Outcomes, and Response to Therapy Among Patients with Acute Exacerbation of Chronic Hepatitis C.
Sagnelli E, Pisaturo M, Stanzione M, , et al
Clin Gastroenterol Hepatol. 2013 Apr 13. .
 Abstract

A Comparison of Modified Directly Observed Therapy to Standard Care for Chronic Hepatitis C.
 Cioe PA, Stein MD, Promrat K, Friedmann PD
 J Community Health. 2013 Mar 8..
 Abstract

FULL-TEXT ARTICLE
 Chronic hepatitis virus infection in patients with multiple myeloma: clinical characteristics and outcomes.
Teng CJ, Liu HT, Liu CY, et al
Clinics (Sao Paulo). 2011;66(12):2055-61
 Paper

Treatment of chronic hepatitis C virus infection. A study of best predictors for response
Ospina N, Rodríguez JL, Hernández M, et al
Rev Esp Quimioter. 2011 Dec;24(4 .
 Abstract

New treatments for chronic hepatitis C virus infection.
 Corouge M, Pol S.
Med Mal Infect. 2011 Jul 15.
 Abstract

Mechanisms of non-response to antiviral treatment in chronic hepatitis C.
 Chevaliez S, Asselah T.
Clin Res Hepatol Gastroenterol. 2011 Jun;35 .
 Abstract

FULL-TEXT PDF ARTICLE
Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: A nested case control study..
 Tran HA, Jones TL, Gibson R, Reeves GE.
 BMC Endocr Disord. 2011 May 24;11(1):10
 Paper

Antiviral therapy: why does it fail in HCV-related chronic hepatitis?
 Masarone M, Persico M.
 Expert Rev Anti Infect Ther. 2011 May;9(5):535-43..
 Abstract

A new standard of care for the treatment of chronic HCV infection.
Hofmann WP, Zeuzem S.
Nat Rev Gastroenterol Hepatol. 2011 Apr 5
 Abstract

Current therapies for chronic hepatitis C.
Ferguson MC.
Pharmacotherapy. 2011 Jan;31(1):92-111.
 Abstract

Treatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis.
Martín-Carbonero L, Tuma P,  et al
J Viral Hepat. 2010 Aug 31
 Abstract

Quality of care in patients with chronic hepatitis C virus infection: a cohort study.
 Kanwal F, Schnitzler MS, Bacon BR, et al
Ann Intern Med. 2010 Aug 17;153(4):231-9
 Abstract

Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in Switzerland.
 Overbeck K, Dufour JF, Müllhaupt B, et al
Swiss Med Wkly. 2010 Feb 3
 Abstract
Non-Responders
 
     Journal Papers, Abstracts, and Commentaries
 
 
Management of nonresponsive hepatitis C.
 Bailly F, Ahmed SN, Pradat P, Trepo C.
 Expert Rev Anti Infect Ther. 2010 Apr;8(4):379-95
 Abstract

Nonresponder Patients with Hepatitis C Virus Genotype 2/3 Infection: A Question of Low Systemic Interferon Concentrations?
Alsiö A, Christensen PB, Färkkilä M,  et al
 Clin Infect Dis. 2010 Jan 20
 Abstract
 
HCV/HBV Coinfection
 

     Journal Papers, Abstracts, and Commentaries

  Epidemiology, natural history, and treatment of hepatitis B virus and hepatitis C virus coinfection.
Perumalswami PV, Bini EJ.
Minerva Gastroenterol Dietol. 2006 Jun;52(2):145-55.
Abstract		  
Adverse Events: General
 
     Journal Papers, Abstracts, and Commentaries
 
 

Hepatitis C Virus Infection and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis.
Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Ungprasert P.
 Ann Hepatol. 2017 Aug 1;
 Abstract

Baseline Comorbidities Enhance the Risk of Treatment-Induced Depression in HCV-Infected Men: A Pilot Study.
 Rempel JD, Krueger C, Minuk GY, Wong SG.
Am J Mens Health. 2014 Feb 3
 Abstract

Late autoimmune hepatitis after hepatitis C therapy.
 Efe C, Heurgué-Berlot A, Ozaslan E,  et al
 Eur J Gastroenterol Hepatol. 2013 Apr 26
 Abstract

Metabolic alterations and chronic hepatitis C: treatment strategies.
 Adinolfi LE, Restivo L, Zampino R, et al
Expert Opin Pharmacother. 2011 Sep 2.
 Abstract

FULL-TEXT ARTICLE
 Management of Hepatitis C Antiviral Therapy Adverse Effects.
 Sung H, Chang M, Saab S.
Curr Hepat Rep. 2011 Mar;10(1):33-40.
 Paper

Management of Hepatitis C Antiviral Therapy Adverse Effects.
Sung H, Chang M, Saab S.
Curr Hepat Rep. 2011 Mar;10(1):33-40..
 Abstract

Sustained Virologic Response Decreases Serum Markers of Angiogenesis, Inflammation, and Fibrosis in HIV/HCV-Coinfected Patients on Hepatitis C Virus Therapy
 García-Álvarez M, Berenguer J, Micheloud D, et al
AIDS Patient Care STDS. 2011 Feb 6.
 Abstract

Major Adverse Cardiac Events in Patients With Hepatitis C Infection Treated With Bare-Metal Versus Drug-Eluting Stents.
Palaniswamy C, Aronow WS, Sukhija R,  et al
Clin Cardiol. 2010 Jun 15;33(6):367-370
 Abstract
Alternative Therapies
 
     Journal Papers, Abstracts, and Commentaries
 
  Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against
Cirrhosis (HALT-C) Trial
 Seeff LB, Curto TM, Szabo G, et al 
Hepatology. 2007 Dec 21
 Abstract
Treatment Failure
 
     Journal Papers, Abstracts, and Commentaries
 
  Retreatment Options Following HCV Direct Acting Antiviral Failure.
 Zuckerman A, Chastain CA, Naggie S.
 Curr Treat Options Infect Dis. 2017
 Abstract

Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure.
 Colpitts CC, Baumert TF.
Viruses. 2016 Aug 16;8(8). pii: E226.
 Abstract

Prevention and management of treatment failure to new oral hepatitis C drugs.
 Benítez-Gutiérrez L, Barreiro P, Labarg a P,  et al
Expert Opin Pharmacother. 2016 Jun;17(9):1215-23.
 Paper

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy.
Backx M, Lewszuk A, White JR, et al.
J Viral Hepat. 2014 Mar;21(3):208-15.
Abstract

Failed triple therapy in a treatment-experienced patient with genotype 6 hepatitis C infection.
 Gammal RS, Spooner LM, Abraham GM.
Am J Health Syst Pharm. 2014 Feb 1;71(3):204-8. .
 Abstract

Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C.
 Soriano V, Vispo E, de Mendoza C, et al
Antivir Ther. 2013 Jun 27.
 Abstract
Economics
 
      Journal Papers, Abstracts, and Commentaries
 
 

FULL-TEXT ARTICLE
Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study.
 Marshall AD, Saeed S, Barrett L, Cooper CL,  et al
 CMAJ Open. 2016 Oct 14;4(4):
 Paper

Cost-Effectiveness of IL28Β Genotype-Guided Protease Inhibitor Triple Therapy versus Standard of Care Treatment in Patients with Hepatitis C Genotypes 2 or 3 Infection.
Bock JA, Fairley KJ, Smith RE,
Public Health Genomics. 2014 Sep 18.
 Abstract
Viral Resistance
 
    Journal Papers, Abstracts, and Commentaries
 
  Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure.
 Colpitts CC, Baumert TF.
Viruses. 2016 Aug 16;8(8). pii: E226.
Abstract
Resources
 
Videos
 
Treatment of Hepatitis C
Sammy Saab, MD, MPH. UCLA Digestive Disease

 

HCV Main Page Main New/Newsworthy    Home Page    

HCV Management